The Scheme of Arrangement was approved by the New Delhi Bench of the NCLT under the provisions of the Companies Act, 2013.

Earlier in February, the New Delhi bench of the National Company Law Tribunal (NCLT) approved the amalgamation of Shree Jee ...

The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench. With this consolidation, the ...

Discover an intriguing stock idea with Mankind Pharma showing signs of a rebound and potential upside in price action.

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at one-tenth of the original cost.

Mankind Pharma has received a ₹183.11 crore tax demand from the Income Tax Department for AY 2014-15 to 2017-18 due to ...

Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...

Photograph: Kind courtesy Mankind Pharma/Facebook.com Mankind Pharma, India's fourth-largest drug firm by market share, plans to come up with its generic version of Novo Nordisk's blockbuster anti ...

Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...

IST, the barometer index, the S&P BSE Sensex, slipped 259.73 points or 0.34% to 77,348.12. The Nifty 50 index declined 66.35 points, or 0.28%, to 23,525.60.

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...